Log in
Sign up
Golden has been acquired by ComplyAdvantage.Read about it here ⟶
‌

US Patent 11878055 Coronavirus vaccine

Patent 11878055 was granted and assigned to BioNTech SE on January, 2024 by the United States Patent and Trademark Office.

OverviewStructured DataIssuesContributorsActivity

All edits

Edits on 30 Jan, 2024
"Created via: Patent importer"
Golden AI profile picture
Golden AI
created this topic on 30 Jan, 2024
Edits made to:
Infobox (+121 properties)
Article (+326 characters)
‌

 US Patent 11878055 Coronavirus vaccine

Article

Patent abstract

This disclosure relates to the field of RNA to prevent or treat coronavirus infection. In particular, the present disclosure relates to methods and agents for vaccination against coronavirus infection and inducing effective coronavirus antigen-specific immune responses such as antibody and/or T cell responses.

Infobox
Is a
Patent
Patent
0
Patent Applicant
‌
BioNTech SE
0
Current Assignee
‌
BioNTech SE
0
Patent Jurisdiction
United States Patent and Trademark Office
United States Patent and Trademark Office
0
Patent Number
118780550
Patent Inventor Names
Alexander Muik0
Hui Cai0
Kayvon Modjarrad0
Kena Anne Swanson0
Qi Yang0
Ugur Sahin0
Date of Patent
January 23, 2024
0
Patent Application Number
183415900
Date Filed
June 26, 2023
0
Patent Citations
‌
US Patent 11110166 Polymeric carrier cargo complex for use as an immunostimulating agent or as an adjuvant
0
‌
US Patent 7736850 Strain of SARS-associated coronavirus and applications thereof
0
‌
US Patent 7901708 Liposomal apparatus and manufacturing methods
0
‌
US Patent 8058069 Lipid formulations for nucleic acid delivery
0
‌
US Patent 8153773 Synthesis and use of anti-reverse phosphorothioate analogs of the messenger RNA cap
0
‌
US Patent 8278036 RNA containing modified nucleosides and methods of use thereof
0
‌
US Patent 8329070 Liposomal apparatus and manufacturing method
0
‌
US Patent 8691966 RNA containing modified nucleosides and methods of use thereof
0
‌
US Patent 8710200 Engineered nucleic acids encoding a modified erythropoietin and their expression
0
‌
US Patent 8748089 RNA containing modified nucleosides and methods of use thereof
0
‌
US Patent 8754062 DLIN-KC2-DMA lipid nanoparticle delivery of modified polynucleotides
0
‌
US Patent 8822663 Engineered nucleic acids and methods of use thereof
0
‌
US Patent 8835108 RNA containing modified nucleosides and methods of use thereof
0
‌
US Patent 8999380 Modified polynucleotides for the production of biologics and proteins associated with human disease
0
‌
US Patent 9220755 Modified polynucleotides for the production of proteins associated with blood and lymphatic disorders
0
‌
US Patent 9221891 In vivo production of proteins
0
‌
US Patent 9283287 Modified polynucleotides for the production of nuclear proteins
0
‌
US Patent 11213482 SARS-CoV-2 subunit vaccine and microneedle array delivery system
0
‌
US Patent 9295717 Vaccine composition comprising 5′-cap modified RNA
0
‌
US Patent 9303079 Modified polynucleotides for the production of cytoplasmic and cytoskeletal proteins
0
‌
US Patent 9334328 Modified nucleosides, nucleotides, and nucleic acids, and uses thereof
0
‌
US Patent 9364435 Lipid formulations for nucleic acid delivery
0
‌
US Patent 9428535 Modified nucleosides, nucleotides, and nucleic acids, and uses thereof
0
‌
US Patent 9464124 Engineered nucleic acids and methods of use thereof
0
‌
US Patent 9476055 Modification of RNA, producing an increased transcript stability and translation efficiency
0
‌
US Patent 9492386 Liposomal apparatus and manufacturing methods
0
‌
US Patent 9504651 Lipid compositions for nucleic acid delivery
0
‌
US Patent 9512456 Enzymes and polymerases for the synthesis of RNA
0
‌
US Patent 9533047 Delivery and formulation of engineered nucleic acids
0
‌
US Patent 9597380 Terminally modified RNA
0
‌
US Patent 9657295 Modified nucleosides, nucleotides, and nucleic acids, and uses thereof
0
‌
US Patent 9669089 Nucleic acid comprising or coding for a histone stem-loop and a poly(A) sequence or a polyadenylation signal for increasing the expression of an encoded pathogenic antigen
0
‌
US Patent 9737619 Lipids and lipid nanoparticle formulations for delivery of nucleic acids
0
‌
US Patent 9738593 Lipids and lipid nanoparticle formulations for delivery of nucleic acids
0
‌
US Patent 9750824 RNA containing modified nucleosides and methods of use thereof
0
‌
US Patent 9850269 Methods for purification of messenger RNA
0
‌
US Patent 9868691 Compounds and compositions for intracellular delivery of therapeutic agents
0
‌
US Patent 9868692 Compounds and compositions for intracellular delivery of therapeutic agents
0
‌
US Patent 9872900 Nucleic acid vaccines
0
‌
US Patent 9957499 Methods for purification of messenger RNA
0
‌
US Patent 9970047 Quantitative assessment for cap efficiency of messenger RNA
0
‌
US Patent 10022435 Nucleic acid vaccines
0
‌
US Patent 10064934 Combination PIV3/hMPV RNA vaccines
0
‌
US Patent 10064935 Human cytomegalovirus RNA vaccines
0
‌
US Patent 10064959 Modified nucleosides, nucleotides, and nucleic acids, and uses thereof
0
‌
US Patent 10106490 Lipids and lipid nanoparticle formulations for delivery of nucleic acids
0
‌
US Patent 10106800 Modification of RNA, producing an increased transcript stability and translation efficiency
0
‌
US Patent 10124055 Zika virus RNA vaccines
0
‌
US Patent 10166298 Lipids and lipid nanoparticle formulations for delivery of nucleic acids
0
‌
US Patent 10207010 Compositions and methods for delivery of agents
0
‌
US Patent 10232055 RNA containing modified nucleosides and methods of use thereof
0
‌
US Patent 10238754 Lipid nanoparticle compositions and methods for MRNA delivery
0
‌
US Patent 10266485 Compounds and compositions for intracellular delivery of therapeutic agents
0
‌
US Patent 10272150 Combination PIV3/hMPV RNA vaccines
0
‌
US Patent 10286086 Alternative nucleic acid molecules and uses thereof
0
‌
US Patent 10273269 High potency immunogenic zika virus compositions
0
‌
US Patent 10350303 Lipid nanoparticle compositions and methods for mRNA delivery
0
‌
US Patent 10385088 Polynucleotide molecules and uses thereof
0
‌
US Patent 10413618 Lipid nanoparticle compositions and methods for mRNA delivery
0
‌
US Patent 10449244 Zika RNA vaccines
0
‌
US Patent 10442756 Compounds and compositions for intracellular delivery of therapeutic agents
0
‌
US Patent 10465190 In vitro transcription methods and constructs
0
‌
US Patent 10493143 Sexually transmitted disease vaccines
0
‌
US Patent 10493167 In vivo production of proteins
0
‌
US Patent 10494399 Compositions and methods for synthesizing 5′-Capped RNAS
0
‌
US Patent 10519189 Compositions and methods for synthesizing 5′-Capped RNAs
0
‌
US Patent 10526629 RNA polymerase variants
0
‌
US Patent 10543269 hMPV RNA vaccines
0
‌
US Patent 10577403 Modified polynucleotides for the production of secreted proteins
0
‌
US Patent 10583203 In vivo production of proteins
0
‌
US Patent 10648017 Methods for RNA analysis
0
‌
US Patent 10653712 High purity RNA compositions and methods for preparation thereof
0
‌
US Patent 10653767 Zika virus MRNA vaccines
0
‌
US Patent 10695419 Human cytomegalovirus vaccine
0
‌
US Patent 10702599 HPIV3 RNA vaccines
0
‌
US Patent 10702600 Betacoronavirus mRNA vaccine
0
‌
US Patent 10703789 Modified polynucleotides for the production of secreted proteins
0
‌
US Patent 10709779 Nucleic acid vaccines
0
‌
US Patent 10717982 Stabilization of poly(A) sequence encoding DNA sequences
0
‌
US Patent 10723692 Lipids and lipid nanoparticle formulations for delivery of nucleic acids
0
‌
US Patent 10738306 Artificial nucleic acid molecules for improved protein or peptide expression
0
‌
US Patent 10760070 Method for producing and purifying RNA, comprising at least one step of tangential flow filtration
0
‌
US Patent 10772975 Modified Polynucleotides for the production of biologics and proteins associated with human disease
0
‌
US Patent 10808242 Method for reducing immunogenicity of RNA
0
‌
US Patent 10857105 Compounds and compositions for intracellular delivery of therapeutic agents
0
‌
US Patent 10858647 Removal of DNA fragments in mRNA production process
0
‌
US Patent 10906944 Stabilized coronavirus spike (S) protein immunogens and related vaccines
0
‌
US Patent 11241493 Coronavirus vaccine
0
‌
US Patent 10912826 Nucleic acid comprising or coding for a histone stem-loop and a poly(A) sequence or a polyadenylation signal for increasing the expression of an encoded pathogenic antigen
0
‌
US Patent 10913768 Compositions and methods for synthesizing 5′-capped RNAs
0
‌
US Patent 10925935 Terminally Modified RNA
0
‌
US Patent 10925958 Influenza vaccine
0
‌
US Patent 10960070 Prefusion coronavirus spike proteins and their use
0
‌
US Patent 10973909 Coronavirus vaccine
0
‌
US Patent 11040112 Lipids and lipid nanoparticle formulations for delivery of nucleic acids
0
‌
US Patent 11045540 Varicella zoster virus (VZV) vaccine
0
‌
US Patent 11278617 Immunogenic composition forming a SARS-CoV-2 vaccine, and a method for its manufacture
0
‌
US Patent 11498944 Compositions and methods for preventing and treating coronavirus infection—SARS-CoV-2 vaccines
0
‌
US Patent 11510977 Nucleic acid vaccines for coronavirus
0
‌
US Patent 11547673 Coronavirus vaccine
0
‌
US Patent 11634379 Lipids and lipid nanoparticle formulations for delivery of nucleic acids
0
Patent Primary Examiner
‌
Barry A Chestnut
0
CPC Code
‌
A61K 39/12
0
‌
A61K 39/215
0
‌
A61P 31/14
0
‌
A61K 2039/55555
0
‌
A61K 2039/53
0

Find more entities like US Patent 11878055 Coronavirus vaccine

Use the Golden Query Tool to find similar entities by any field in the Knowledge Graph, including industry, location, and more.
Open Query Tool
Access by API
Golden Query Tool
Golden logo
By using this site, you agree to our Terms of Service.